Probable medication-overuse headache - The effect of a 2-month drug-free period

被引:131
作者
Zeeberg, Peter [1 ]
Olesen, Jes [1 ]
Jensen, Rigmor [1 ]
机构
[1] Univ Copenhagen, Glostrup Hosp, Dept Neurol, Danish Headache Ctr, DK-2600 Glostrup, Denmark
关键词
D O I
10.1212/01.wnl.0000217914.30994.bd
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To describe the emerging profile of headache frequency following a 2-month drug-free period in patients with medication overuse. Methods: All patients treated and discharged from Danish Headache Center in 2002 and 2003 had prospectively filled out a diagnostic headache diary on a daily basis. For patients with probable medication-overuse headache ( MOH), the authors determined headache frequencies before and after medication withdrawal from these prospective recordings. Results: Among 1,326 patients, 337 had probable MOH. Two hundred sixteen patients who stayed medication-free for 2 months were eligible. Overall, 45% of the patients improved, 48% had no change, and 7% had more headaches. Median age was 48 years, and male/female ratio 1:2.7. The relative reduction in headache frequency varied considerably with a 67% median reduction in migraine, 0% in tension-type headache (TTH), and 37% in patients with both migraine and TTH (MT). Comparing the diagnostic groups, the relative reduction in frequency differed between migraine and TTH (p < 0.001) and between MT and TTH (p < 0.01). Triptan/ergot overusers improved the most (p < 0.0001). The difference between MT and TTH remained significant when triptan/ergot overuse was controlled (p < 0.05). Conclusion: These data demonstrate the benefit of withdrawal in already established medication overuse and support the existence of medication-overuse headache as a clinical entity.
引用
收藏
页码:1894 / 1898
页数:5
相关论文
共 15 条
[1]
Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache [J].
Bendtsen, L ;
Jensen, R .
NEUROLOGY, 2004, 62 (10) :1706-1711
[2]
A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache [J].
Bendtsen, L ;
Jensen, R ;
Olesen, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 61 (03) :285-290
[3]
Transformed migraine and medication overuse in a tertiary headache centre - clinical characteristics and treatment outcomes [J].
Bigal, ME ;
Rapoport, AM ;
Sheftell, FD ;
Tepper, SJ ;
Lipton, RB .
CEPHALALGIA, 2004, 24 (06) :483-490
[4]
Overuse of symptomatic medications among chronic (transformed) migraine patients - Profile of drug consumption [J].
Krymchantowski, AV .
ARQUIVOS DE NEURO-PSIQUIATRIA, 2003, 61 (01) :43-47
[5]
Chronic headache - New advances in treatment strategies [J].
Lake, AE ;
Saper, JR .
NEUROLOGY, 2002, 59 (05) :S8-S13
[6]
Features of medication overuse headache following overuse of different acute headache drugs [J].
Limmroth, V ;
Katsarava, Z ;
Fritsche, G ;
Przywara, S ;
Diener, HC .
NEUROLOGY, 2002, 59 (07) :1011-1014
[7]
Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication:: a retrospective study [J].
Linton-Dahlöf, P ;
Linde, M ;
Dahlöf, C .
CEPHALALGIA, 2000, 20 (07) :658-662
[8]
DRUG-INDUCED REFRACTORY HEADACHE - CLINICAL-FEATURES AND MANAGEMENT [J].
MATHEW, NT ;
KURMAN, R ;
PEREZ, F .
HEADACHE, 1990, 30 (10) :634-638
[9]
Analgesic rebound headache in clinical practice: Data from a physician survey [J].
Rapoport, A ;
Stang, P ;
Gutterman, DL ;
Cady, R ;
Markley, H ;
Weeks, R ;
Saiers, J ;
Fox, AW .
HEADACHE, 1996, 36 (01) :14-19
[10]
PRESENTATION OF A NEW INSTRUMENT - THE DIAGNOSTIC HEADACHE DIARY [J].
RUSSELL, MB ;
RASMUSSEN, BK ;
BRENNUM, J ;
IVERSEN, HK ;
JENSEN, RA ;
OLESEN, J .
CEPHALALGIA, 1992, 12 (06) :369-379